Avid Bioservices Inc buy Quitte
Start price
15.10.15
/
50%
€6.76
Target price
15.04.16
€7.70
Performance (%)
-64.12%
End price
15.04.16
€2.42
Summary
This prediction ended on 15.04.16 with a price of €2.42. Massive losses of -64.12% were the result for the BUY prediction by Quitte. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Avid Bioservices Inc | 6.857% | 6.857% | -20.085% | -56.713% |
iShares Core DAX® | -0.621% | 1.080% | 11.291% | 16.439% |
iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% | 39.304% |
iShares Nikkei 225® | -2.562% | -1.617% | 7.262% | 8.383% |
iShares S&P 500 | -1.706% | -1.223% | 22.550% | 40.997% |
Comments by Quitte for this prediction
In the thread Avid Bioservices Inc diskutieren
aussichtsreich
AstraZeneca and Peregrine Pharmaceuticals Expand Ongoing Immuno-Oncology Collaboration to Include Phase II Lung Cancer Combination Clinical Trial
By GlobeNewswire, October 15, 2015, 08:05:00 AM EDT
Read more: http://www.nasdaq.com/press-release/astrazeneca-and-peregrine-pharmaceuticals-expand-ongoing-immunooncology-collaboration-to-include-20151015-00403#ixzz3oeFAlads
Quitte stimmt am 15.10.2015 dem Sell-Crowdsentiment mit dem Kursziel 0.61€ nicht zu.
(Laufzeit überschritten)
Stopped prediction by Quitte for Avid Bioservices Inc
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€8.05
03.12.20
03.12.20
€9.00
03.12.21
03.12.21
200.62%
04.12.21
04.12.21
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€1.90
12.12.16
12.12.16
€3.97
28.05.18
28.05.18
60.89%
28.05.18
28.05.18
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€2.57
20.04.16
20.04.16
€3.79
20.10.16
20.10.16
-16.93%
20.10.16
20.10.16
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€10.67
09.03.15
09.03.15
€12.95
09.09.15
09.09.15
-31.50%
09.09.15
09.09.15